Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer

MLA

Xiao-Guang Li, et al. “Truncated HDAC9 Identified by Integrated Genome-Wide Screen as the Key Modulator for Paclitaxel Resistance in Triple-Negative Breast Cancer.” Theranostics, vol. 10, no. 24, Feb. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f216abc1f8d7277609adefd214a6f484&authtype=sso&custid=ns315887.

APA

Xiao-Guang Li, Zhi-Ming Shao, Mengzhu Xue, Yi-Zi Zheng, Feng Qiao, Yu-Chen Pei, Yi-Zhou Jiang, Min He, Xi-Yu Liu, Wei-Li Sun, Bi Lian, Xin Hu, Da-Qiang Li, Hong Ling, & Ling Yao. (2020). Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer. Theranostics, 10(24).

Chicago

Xiao-Guang Li, Zhi-Ming Shao, Mengzhu Xue, Yi-Zi Zheng, Feng Qiao, Yu-Chen Pei, Yi-Zhou Jiang, et al. 2020. “Truncated HDAC9 Identified by Integrated Genome-Wide Screen as the Key Modulator for Paclitaxel Resistance in Triple-Negative Breast Cancer.” Theranostics 10 (24). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f216abc1f8d7277609adefd214a6f484&authtype=sso&custid=ns315887.